Susquehanna International Group’s ASLAN Pharmaceuticals ASLN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASLN
Susquehanna International Group's ASLN Position: Q1 2022 in Review
Susquehanna International Group sold out of ASLAN Pharmaceuticals (ASLN) in Q1 2022, closing a stake of 470 shares — an estimated $21K sold.
Susquehanna International Group first reported a position in ASLN in Q4 2019 and held it in 5 quarters. The position peaked at $399K in Q3 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q1 2022.
- Susquehanna International Group reported no remaining ASLAN Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
- Susquehanna International Group sold 470 ASLAN Pharmaceuticals shares in Q1 2022, an estimated $21K.
- Susquehanna International Group first reported a position in ASLAN Pharmaceuticals in Q4 2019 and held it in 5 quarters.
- Susquehanna International Group's ASLAN Pharmaceuticals position peaked at $399K in Q3 2021.
- 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.